Date updated:02-23-2008
The following is a list of companies from a collection of various research reports.

-
CZN
Czn - $0.00
- N/A
- $N/A
Buy-- Price 10.94 on Feb. 19 by Hilliard Lyons CZN's 9.1% dividend yield [makes it] one of the five highest-yielding stocks in the Standard & Poor's 500... . The stock has declined by 32% from its 52-week high ... yet fundamentals [haven't] materially changed. CZN typically has an [earnings before interest, depreciation, taxes and amortization] margin in the mid-50% range, [quite high among] rural local-exchange carriers... . We expect "08 [free cash flow] of $500 million. 13 target. Market-cap: $3.7 billion.

-
FBCM
Fbr Capital Marke - $5.04
- +1.82%
- $5.00
Buy-- Price 6.69 on Feb. 20 by Think Equity FBCM reported weak 4Q results [amid] a difficult capital-markets environment and subdued capital-raising ... Investment-banking revenue fell 62% y/o/y, a 54% sequential decrease. While ... FBCM's pipeline [looks] relatively solid, challenging market conditions could continue to weigh on capital-raising activity near-term. We're lowering FY08 EPS estimate from 76 cents to 11 cents but maintain Buy. Given net cash of $6 a share and book value of $7.91 a share, we believe downside ... is limited. Target: 8 [from 15]. Market-cap: $430 million.

-
GWR
Genesee - $32.00
- +2.20%
- $31.55
Outperform-- Price 27.12 on Feb. 19 by Morgan Keegan [This leading international short-line railroad with 5,900+ track miles and another 3,700 via access arrangement] reported 4Q07 [earnings per share] of 37 cents -- beating our and management estimates... . Based on our increased fiscal-year "08 earnings estimate of $1.70 a share, GWR trades at 17.4 times... . GWR benefits from accretive acquisitions ... [plus] growth in nonfreight revenues and pricing power. Market-cap: $957 million.

-
NOVA
Novamed - $3.29
- +8.94%
- $3.15
Strong Buy-- Price 3.86 on Feb. 19 by Raymond James NovaMed reported normalized 4Q07 EPS from continuing operations of 8 cents... . Overall, 4Q results were better than expected (especially considering recent lack of enthusiasm for its shares -- trading at near-historic lows) and consistent with our recent upgrade on Jan. 25 from Outperform to Strong Buy (at $2.96), as same-facility revenue growth (+9% y/o/y) ... coupled with improved volumes in 4Q, [were seen to] act as catalysts for outperformance heading into 2008. Market-cap: $97 million.

-
RCL
Royal Caribbean C - $14.80
- -2.50%
- $15.08
Outperform-- Price 37.23 on Feb. 19 by Bear Stearns [Due to cost increases,] we are lowering our 1Q08 EPS to 27 cents (from 30 cents) and 2008 EPS to $3.22 (from $3.25). We maintain our "08 year-end target, 49, which we base on 13.5 times our 2009 EPS of $3.60. Risks relate to rising fuel expense and the impact of a slowing [of] leisure consumer[s] given continued macroeconomic weakness. Market-cap: $10.4 billion.

-
SCOM.OB
Sharps Compliance - $1.60
- 0.00%
- $N/A
Buy-- Price 2.45 on Feb. 20 by Red Chip Visibility Research We believe SCOM is well-positioned to capitalize on a burgeoning medical-waste market driven by government regulation and public awareness of proper disposal of medical waste. Initiating coverage with Buy rating and 6.30 target. Market-cap: $30 million.

-
SINT
Sint - $0.00
- N/A
- $N/A
Neutral-- Price 23.80 on Feb. 19 by Jesup & Lamont We believe IT-contractor SINT is well-positioned with the Air Force and to benefit from transformation of the military. But ... given SINT's "07 organic growth of 3.2% down from 8% in 2006, we['d] stay on the sidelines... . For 2009E we forecast EPS $1.84. Market-cap: $316.5 million.

-
TASR
Taser Internation - $5.51
- -1.08%
- $5.65
Buy-- Price 12 on Feb. 20 by Garp Research Despite a 60% jump in revenue and near doubling of EPS in 4Q07, TASR shares dropped by 10% ... in "07, TASR experienced a net decline in outstanding wrongful-death cases for the first time ever ... We think investor focus on gross margin compression is misplaced because the real story is the company's sizable operating leverage, which could lead to an incremental operating margin of 40% to 50% for "08. Market-cap: $725 million.
- Barron's Research Reports 2-23-2008's Blog
- No Blogs Found
- Top Professional Portfolios
- 1. Charlie Munger
- 2. Bernard L. Madoff Inve...
- 3. Renaissance Technologies
- 4. Templeton World A (TEMWX)
- 5. Fidelity Select Consum...
- show all
- Top Do-It-Yourself Portfolios
- » Joy
- » tsamanuli Portfolio 1
- » brueckenc Portfolio 1
- » HMH1
- » Fundsonly Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » 10 Short Squeezes
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- show all
Investors were spooked on Wednesday as bleak broad-based corporate outlooks and dismal employment data dominated headlines. Stocks experienced their largest drop in more t...
At Stockpickr.com, we strive to keep track of insider purchasing and buybacks each week. Here's the perfect setup in my mind: insiders buying the stock, the company buying ...
The traders of CNBC’s "Fast Money" think the current stock market is a traders' market. In order to play a traders' market, you have to nimble. You also have to know whic...
Pfizer (PFE) CEO Jeff Kindler has hinted that the world’s biggest drugmaker is open to a large-scale acquisition. “The real goal is to grow revenues," he told the Fina...
A. agree with mike, if you are new to
investing the market the best think you
can do right now is watch. The market
is not cheap in any way right now other
than the comparsion of where it just was
over a year ago. The market and economy
are going to a lot longer than what most
people think to become stable let alone
recover.
A. small trading before thrusday
This is a screen of large cap stocks, i.e. with market capitalizations greater than or equal to $5 billion that also have a P/E less than or equal to 15 and a quick ratio o... more
These stocks were upgraded by TheStreet.com Ratings on Dec. 29, 2008. more
Here are some of the largest % gainers from Jan. 7, 2009. more








Comments not available